Full-Time

Business Development Director

Serán BioScience

Serán BioScience

51-200 employees

CDMO offering drug formulation & manufacturing

No salary listed

Bend, OR, USA

Hybrid

Hybrid role based in Bend, OR; 25-50% travel (domestic with potential international travel).

Category
Business & Strategy (1)
Required Skills
Sales
Lead Generation
Requirements
  • Excellent verbal and written communication skills
  • Excellent interpersonal, business, and customer service skills
  • Excellent organizational skills and attention to detail
  • Excellent negotiation skills, with ability follow-through on customer contracts/management
  • Excellent time management skills with a proven ability to meet deadlines
  • Ability to prioritize tasks and to delegate them when appropriate
  • Ability to function well in a high-paced and at times stressful environment
  • Proficient with CRM, Office and other related software
  • Minimum requirement of a Bachelor’s degree in a related scientific discipline
  • 5+ years of experience in pharmaceutical industry
  • Travel approximately 25% required, and at times > 50% may be required; Travel will be domestic, with potential for international travel
  • Prolonged periods of sitting at a desk and working on a computer
  • Must be able to lift to 15 pounds at a time
Responsibilities
  • Generate new leads and opportunities leveraging Serán’s and the incumbents network
  • Build solid, trusting, and measurable relationships with clients and companies while developing a complete understanding of client needs
  • Participate in client visits, regional and national trade shows, and conferences as required
  • Manage both Serán’s existing pipeline and new business opportunities
  • Manage communications between customer and internal teams and assist with management of team activities assigned to each of your customers
  • Work with various internal stakeholders (e.g., Executive, Tech Ops, Project Mgmt, etc.) to build client relationships and improve customer results
  • Contribute to the development of proposals and presentations for new business development materials
  • Adeptly present Serán’s capabilities and value proposition to new clients
  • Negotiate agreements as part of a team with BD, corporate, and legal leadership, including CDAs, MSAs, and commercial supply agreements
  • Resolve client issues, complaints and anticipate key account improvements by way of project management guidance and outreach
  • Identify market trends and customer needs, building a short/medium/long-term sales pipeline in accordance with targets
  • Participate in site management team and planning meetings, including setting objectives and strategies as well as take accountability for implementation and results
  • Support the broader BD team in developing new service offerings and analyzing market trends
  • Assist in the coordination and implementation of marketing strategies, and delegate tasks that achieve strategic goals
  • Responsibilities may increase in scope to align with company initiatives
  • Additional related duties as assigned
Desired Qualifications
  • 2+ years of experience in a client-facing capacity is ideal but additional training can be provided
  • Track record of technical leadership, including technical conference and client presentations

Serán Bioscience is a contract development and manufacturing organization (CDMO) that helps pharmaceutical companies develop and manufacture drugs. It provides preformulation, formulation and dosage form development, spray drying and particle engineering, and cGMP manufacturing and analytical quality control to move drugs from concept to scalable production. Its services revolve around designing and optimizing drug formulations and production processes, with rigorous analytical testing to ensure safety and quality. It differentiates itself with a flexible, client-tailored approach and a broad toolkit, especially in spray drying and particle engineering, all under strict cGMP standards. Its goal is to help clients—from startups to large pharma—bring safe, effective therapies to market efficiently and reliably.

Company Size

51-200

Company Stage

Growth Equity (Venture Capital)

Total Funding

$200M

Headquarters

Bend, Oregon

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • $200M Bain Capital funding fuels 100,000 sq ft commercial facility opening Q2 2027.
  • Oregon Bioscience apprenticeship trains technicians, resolving cGMP labor shortages.
  • Mortenson partnership accelerates campus expansion, positioning Bend as life sciences hub.

What critics are saying

  • Lonza's US oral solid dosage expansion secures large pharma deals, eroding Serán's share.
  • Catalent's Novo Holdings acquisition floods market with cheap CDMO capacity, undercutting rates.
  • Bain Capital demands premature scaling post-2024 investment, triggering quality failures.

What makes Serán BioScience unique

  • Serán excels in spray drying and particle engineering for complex small-molecule bioavailability.
  • Bend campus integrates preclinical to commercial cGMP manufacturing seamlessly.
  • Bio-performance modeling de-risks early formulations using milligram API quantities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Retirement Plan

Health Insurance

Life Insurance

Disability Insurance

Mental Health Support

Pet Insurance

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

19%
Daily Journal of Commerce
Jan 29th, 2026
Building Blocks: Serán Bioscience facility

Building Blocks: Serán Bioscience facility. PROJECT: Serán Bioscience commercial manufacturing facility OWNER: Serán Bioscience PROJECT DESCRIPTION: Serán Bioscience LLC, in collaboration with Mortenson, is creating a CGMP (Current Good Manufacturing Process) facility in Bend. Slated to open in fall 2027, it will be the third building and centerpiece of Serán's new 100,000-square-foot commercial campus. The team is employing a progressive design-build approach for the project. A topping-out ceremony for the new building was held earlier this month, marking the transition from structural work to interior build-out. Approximately four acres of the 14-acre campus are being used, allowing room for future development. The latest building marks a milestone in Serán's mission to provide fully integrated support, including preclinical services, clinical trial product manufacturing, and commercial-scale production of modern therapeutics. Last fall, Serán completed two new warehouse and light manufacturing buildings totaling 50,000 square feet. These spaces support critical materials handling, packaging, labeling and logistics functions. The commercial site will operate as an extension of the company's 90,000-square-foot clinical development and manufacturing campus nearby. "Building Blocks" spotlights noteworthy projects either under construction or approaching the start of construction. To submit a project for consideration, please visit: djcoregon.com/building-blocks.

KTVZ
Jan 9th, 2026
Serán Bioscience holds topping-out ceremony for new NE Bend manufacturing facility

Serán Bioscience holds topping-out ceremony for new NE Bend manufacturing facility. BEND, Ore. (KTVZ) - Serán Bioscience, LLC, in collaboration with leading developer and design-builder Mortenson, hosted a topping-out ceremony on Thursday to celebrate the construction progress of a new commercial-scale cGMP pharmaceutical and biotech manufacturing facility in northeast Bend. The topping-out ceremony marks the transition from structural construction to interior build-out. Slated to open in the second quarter, the facility on NE Triton Place is the third building and the centerpiece of Serán's new 100,000-square-foot commercial manufacturing campus, the company said in a news release that continues in full below: The campus positions Bend as a growing hub for advanced pharmaceutical development while supporting flexible end-to-end solutions for complex medicines and helping pharmaceutical partners accelerate their pipelines. The expansion marks a significant milestone in Serán's mission to provide fully integrated support starting with drug discovery and pre-clinical services, to first-in-human (FiH) trials, and ultimately to commercial-scale production of small-molecule therapeutics. Adjacent to the manufacturing facility, Serán last fall completed two new warehouse and light manufacturing buildings totaling 50,000 square feet. These spaces support critical materials handling, packaging, labeling and logistics functions, helping ensure efficient scale-up and dependable supply chain execution. "Our clients are bringing forward increasingly sophisticated pharmaceuticals which demands equally sophisticated development and manufacturing capabilities," said Dan Smithey, CEO of Serán BioScience. "Serán is a partner that can solve challenges early and then reliably carry those solutions through to commercial production, and this investment in our campus strengthens our ability to do exactly that. We appreciate the close collaboration with our development and construction partner, Mortenson, as we bring this next phase of Serán's growth to life." "Serán's project reflects the level of technical complexity and quality standards we see driving growth in life sciences manufacturing today," said Pat Clemons, project executive with Mortenson. "Our team is proud to support a facility that is purpose-built for advanced pharmaceutical production while contributing to the long-term economic strength of the Bend region." Located just minutes from Serán's existing 90,000-square-foot clinical development and manufacturing campus, the new commercial site will operate as a seamless extension of the company's established clinical operations and is expected to add as many as 150 employees as manufacturing expands. Serán's Bend-based workforce currently includes more than 190 highly skilled professionals across 10 specialized buildings, equipped with advanced technologies such as nano milling, micronization, dry and wet granulation, single and multi-layer tableting, aqueous and organic solvent coating, encapsulation, spray-dried dispersions, powder for inhalation and twin-screw melt extrusion. Together, these capabilities support oral solid dose programs from early formulation through commercial manufacturing, packaging and labeling. Founded in Bend in 2016, Serán is a leading contract development and manufacturing organization providing a comprehensive suite of development, analytical and clinical manufacturing services to pharmaceutical and biotechnology companies. Serán's deep experience and expertise in materials science, formulation development, particle and process engineering and pharmaceutical manufacturing enables optimum solutions for their customers' most difficult drug development challenges. "We're proud to support Serán's continued investment in Bend and its commitment to serving both emerging biotechnology companies and global pharmaceutical organizations," said Mike Clifford, Vice President and General Manager at Mortenson. "This is a significant life sciences project for Central Oregon. By delivering flexible, science-driven facilities, we're helping translate innovation into commercially viable therapies while contributing to the continued growth of the region's life sciences market." About Serán BioScience Serán BioScience partners with pharmaceutical and biotechnology companies to accelerate the development and production of complex, patient-centric medicines. The Bend facility reflects the company's long-term investment in innovation, workforce growth, and collaboration, enhancing Serán's ability to support the next generation of pharmaceutical solutions while strengthening the regional life sciences ecosystem. Mortenson is a U.S.-based, top-20 builder, developer, and engineering services provider serving the commercial, institutional, and energy sectors. Mortenson's expanding portfolio of integrated services helps its customers move their strategies forward, ensuring their investments result in high-performing assets. The result is a turnkey partner, fully invested in the business success of its customers. Founded in 1954, Mortenson has operations across the U.S. with offices in Chicago, Denver, Fargo, Iowa City, Milwaukee, Minneapolis, Nashville, Phoenix, Portland, Salt Lake City, San Antonio, Seattle, and Washington, D.C. For additional information, visit www.mortenson.com.

Bain Capital
Nov 18th, 2024
Serán Bioscience Announces $200 Million Strategic Growth Transaction and Plans for New Commercial Facility

Serán Bioscience announces $200 million strategic growth transaction and plans for new commercial facility.

TechMub
Sep 17th, 2024
Serán Bioscience Raises $200M for Strategic Expansion and New Commercial Facility

With over 200 team members, including 150 scientists and engineers, Serán plans to add 150 more employees as part of its expansion.

Contract Pharma
Sep 17th, 2024
Serán Bioscience Plans New Commercial-Scale Manufacturing Facility

Serán Bioscience, a contract development and manufacturing organization (CDMO) providing a comprehensive suite of development, analytical, and manufacturing services to pharmaceutical and biotechnology companies, has announced a strategic growth transaction of more than $200 million, which will support Serán's continued growth and construction of a new commercial-scale manufacturing facility.